misonneh's tamoxifen [53 articles] Export

Recent papers added to misonneh's library classified by the tag tamoxifen. You can also see everyone's tamoxifen.

	Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer. [My Copy] Carcinogenesis, Vol. 29, No. 7. (July 2008), pp. 1459-1465. by Benjamin A. Rodriguez, Alfred S. Cheng, Pearlly S. Yan, et al.Dustin Potter, Francisco J. Agosto-Perez, Charles L. Shapiro, Tim H-M H. Huang posted to tamoxifen polycomb phenotype moa estrogen epigenetics breast by misonneh on 2009-11-24 06:51:57 as
	Genetic matters of CYP2D6 in breast cancer: copy number variations and nucleotide polymorphisms [My Copy] Nat Rev Cancer, Vol. 9, No. 11. (23 October 2009), pp. 842-843. by Ke-Da Yu, Zhi-Ming Shao posted to tamoxifen review pharmacogenetics genetics cyp2d6 comments breast by misonneh on 2009-11-19 05:26:25 as
	Genetic polymorphisms of CYP2D6 10 and CYP2C19 2, 3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen. [My Copy] Cancer, Vol. 115, No. 5. (1 March 2009), pp. 952-961. by Masatsugu Okishiro, Tetsuya Taguchi, Seung Jin Kim, Kenzo Shimazu, Yasuhiro Tamaki, Shinzaburo Noguchi posted to tamoxifen pharmacogenetics cyp2d6 breast asian_populations by misonneh on 2009-10-27 07:17:16 as along with 2 people ilsun Mi-Seon
	Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. [My Copy] Journal of the National Cancer Institute, Vol. 95, No. 23. (3 December 2003), pp. 1758-1764. by Vered Stearns, Michael D. Johnson, James M. Rae, et al.Alan Morocho, Antonella Novielli, Pankaj Bhargava, Daniel F. Hayes, Zeruesenay Desta, David A. Flockhart posted to tamoxifen pk pharmacogenetics metabolism ddi breast by misonneh on 2009-10-27 07:02:30 as
	CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. [My Copy] Journal of the National Cancer Institute, Vol. 97, No. 1. (5 January 2005), pp. 30-39. by Yan Jin, Zeruesenay Desta, Vered Stearns, et al.Bryan Ward, Herbert Ho, Kyung-Hoon H. Lee, Todd Skaar, Anna Maria M. Storniolo, Lang Li, Adjei Araba, Rebecca Blanchard, Anne Nguyen, Lynda Ullmer, Jill Hayden, Suzanne Lemler, Richard M. Weinshilboum, James M. Rae, Daniel F. Hayes, David A. Flockhart posted to tamoxifen pharmacogenetics genetics ddi cyp2d6 breast by misonneh on 2009-10-27 07:01:49 as along with 1 person frohike
	Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment. [My Copy] Clinical pharmacology and therapeutics, Vol. 80, No. 1. (July 2006), pp. 61-74. by Silvana Borges, Zeruesenay Desta, Lang Li, et al.Todd C. Skaar, Bryan A. Ward, Anne Nguyen, Yan Jin, Anna Maria M. Storniolo, D. Michele Nikoloff, Lin Wu, Grant Hillman, Daniel F. Hayes, Vered Stearns, David A. Flockhart posted to tamoxifen pk pharmacogenetics metabolism cyp2d6 breast by misonneh on 2009-10-27 07:01:06 as
	Germline pharmacogenetics of tamoxifen response: have we learned enough? [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 25, No. 33. (20 November 2007), pp. 5147-5149. by Zeruesenay Desta, David A. Flockhart posted to tamoxifen pharmacogenetics genetics cyp2d6 comments breast by misonneh on 2009-10-27 06:59:30 as
	Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen [My Copy] JAMA, Vol. 302, No. 13. (7 October 2009), pp. 1429-1436. by Werner Schroth, Matthew P. Goetz, Ute Hamann, et al.Peter A. Fasching, Marcus Schmidt, Stefan Winter, Peter Fritz, Wolfgang Simon, Vera J. Suman, Matthew M. Ames, Stephanie L. Safgren, Mary J. Kuffel, Hans U. Ulmer, Julia Bolander, Reiner Strick, Matthias W. Beckmann, Heinz Koelbl, Richard M. Weinshilboum, James N. Ingle, Michel Eichelbaum, Matthias Schwab, Hiltrud Brauch posted to tamoxifen prognosis prediction pharmacogenetics genotype cyp2d6 breast by misonneh on 2009-10-26 06:36:40 as along with 2 people songpku merpublic
	Estrogen receptor genotype is associated with risk of venous thromboembolism during tamoxifen therapy. [My Copy] Breast cancer research and treatment, Vol. 115, No. 3. (June 2009), pp. 643-650. by Adedayo A. Onitilo, Catherine A. McCarty, Russell A. Wilke, et al.Ingrid Glurich, Jessica M. Engel, David A. Flockhart, Anne Nguyen, Lang Li, Deming Mi, Todd C. Skaar, Yan Jin posted to tamoxifen pharmacogenetics hr genetics breast adr by misonneh on 2009-10-21 02:21:36 as
	Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growth. [My Copy] Breast cancer research and treatment, Vol. 96, No. 2. (March 2006), pp. 131-146. by D. J. Britton, I. R. Hutcheson, J. M. Knowlden, et al.D. Barrow, M. Giles, R. A. McClelland, J. M. Gee, R. I. Nicholson posted to tamoxifen resistance esr1 egfr_pathway breast by misonneh on 2009-09-28 06:37:09 as along with 2 people Zephyrus SChewchuk
	No Increase in Breast Cancer Recurrence with Concurrent Use of Tamoxifen and Some CYP2D6-Inhibiting Medications [My Copy] Cancer Epidemiology Biomarkers & Prevention, Vol. 18, No. 9. (September 2009), pp. 2562-2564. by Thomas P. Ahern, Lars Pedersen, Deirdre P. Cronin-Fenton, Henrik T. SÃ¸rensen, Timothy L. Lash posted to tamoxifen pharmacogenetics ddi cyp2d6 breast by misonneh on 2009-09-25 06:27:56 as
	Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells. [My Copy] Cancer research, Vol. 67, No. 3. (1 February 2007), pp. 1352-1360. by Ping Fan, Jiping Wang, Richard J. Santen, Wei Yue posted to tamoxifen resistance esr1 egfr_pathway breast by misonneh on 2009-09-08 07:16:38 as
	Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells. [My Copy] Advances in experimental medicine and biology, Vol. 630 (2008), pp. 19-34. by Richard J. Santen, Robert X. Song, Shigeru Masamura, et al.Wei Yue, Ping Fan, Tetsuya Sogon, Shin-ichi Hayashi, Kei Nakachi, Hidtek Eguchi posted to tamoxifen review resistance moa estrogen breast by misonneh on 2009-09-08 07:14:52 as
	Biological determinants of endocrine resistance in breast cancer [My Copy] Nat Rev Cancer, Vol. 9, No. 9. (September 2009), pp. 631-643. by Elizabeth A. Musgrove, Robert L. Sutherland posted to tamoxifen review resistance moa hormone breast by misonneh on 2009-08-26 11:07:26 as along with 1 person songpku
	Genotype-guided tamoxifen therapy: time to pause for reflection? [My Copy] The Lancet Oncology, Vol. 10, No. 8. (August 2009), pp. 825-833. by Timothy L. Lash, Ernst A. Lien, Henrik T. Sørensen, Stephen Hamilton-Dutoit posted to tamoxifen review pharmacogenetics perspective genetics comments by misonneh on 2009-07-30 01:47:41 as
	CYP2D6 and tamoxifen: DNA matters in breast cancer [My Copy] Nat Rev Cancer, Vol. 9, No. 8. (August 2009), pp. 576-586. by Janelle M. Hoskins, Lisa A. Carey, Howard L. Mcleod posted to breast cyp2d6 pharmacogenetics resistance review tamoxifen by misonneh on 2009-07-27 08:49:07 as
	"Dwarf" Estrogen Receptor in Breast Cancer and Resistance to Tamoxifen [My Copy] J Clin Oncol, Vol. 27, No. 21. (20 July 2009), pp. 3413-3415. by Amy M. Fowler, Richard J. Santen, D. Craig Allred posted to alternative breast esr1 moa resistance splicing tamoxifen by misonneh on 2009-07-17 05:33:49 as
	MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment. [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, No. 14. (7 April 2009), pp. 5837-5841. by S. P. Pitroda, N. N. Khodarev, M. A. Beckett, D. W. Kufe, R. R. Weichselbaum posted to breast epistasis pharmacogenetics statistics tamoxifen gwas by misonneh on 2009-06-08 02:46:13 as
	Hepatic complications of breast cancer [My Copy] The Lancet Oncology, Vol. 10 (June 2009), pp. 615-651. by Jennifer R. Diamond, Christina A. Finlayson, Virginia F. Borges posted to adr breast review tamoxifen by misonneh on 2009-06-02 06:25:22 as
	Functional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolites. [My Copy] Cancer research, Vol. 69, No. 5. (1 March 2009), pp. 1892-1900. by A. S. Blevins-Primeau, D. Sun, G. Chen, et al.A. K. Sharma, C. J. Gallagher, S. Amin, P. Lazarus posted to invivo tamoxifen ugt by misonneh on 2009-05-29 09:56:07 as
	Potential Role of UGT Pharmacogenetics in Cancer Treatment and Prevention: Focus on Tamoxifen [My Copy] Annals of the New York Academy of Sciences, Vol. 1155, No. 1., pp. 99-111. by Philip Lazarus, Andrea S. Blevins-Primeau, Yan Zheng, Dongxiao Sun posted to pharmacogenetics review tamoxifen ugt by misonneh on 2009-05-29 09:55:26 as
	Are We Hitting the Right Combination for Hormonally Sensitive Breast Cancer? [My Copy] J Clin Oncol, Vol. 27, No. 16. (1 June 2009), pp. 2580-2582. by Debu Tripathy posted to breast comments hormone moa pharmacogenetics review tamoxifen by misonneh on 2009-05-29 06:45:04 as
	Pharmacogenetics of tamoxifen: who should undergo CYP2D6 genetic testing? [My Copy] Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 7, No. 2. (February 2009), pp. 203-213. by M. J. Higgins, J. M. Rae, D. A. Flockhart, D. F. Hayes, V. Stearns posted to comments cyp2d6 pharmacogenetics tamoxifen by misonneh on 2009-04-14 06:20:53 as along with 1 person dbs
	Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. [My Copy] J Natl Cancer Inst, Vol. 99, No. 4. (21 February 2007), pp. 283-290. by T. J. Powles, S. Ashley, A. Tidy, I. E. Smith, M. Dowsett posted to breast prevention randomized_controlled_trial tamoxifen by misonneh on 2009-04-02 09:06:15 as along with 1 person jfr
	Prevention of Breast Cancer in Postmenopausal Women: Approaches to Estimating and Reducing Risk [My Copy] J. Natl. Cancer Inst., Vol. 101, No. 6. (18 March 2009), pp. 384-398. by Steven R. Cummings, Jeffrey A. Tice, Scott Bauer, et al.Warren S. Browner, Jack Cuzick, Elad Ziv, Victor Vogel, John Shepherd, Celine Vachon, Rebecca Smith-Bindman, Karla Kerlikowske posted to breast chemoprevention meta_analysis modeling prevention review tamoxifen by misonneh on 2009-03-18 00:39:25 as along with 1 person and 1 group Zephyrus Breast Cancer Reading Club
	The Tamoxifen Metabolite, Endoxifen, Is a Potent Antiestrogen that Targets Estrogen Receptor alpha for Degradation in Breast Cancer Cells [My Copy] Cancer Res, Vol. 69, No. 5. (1 March 2009), pp. 1722-1727. by Xianglin Wu, John R. Hawse, Malayannan Subramaniam, Matthew P. Goetz, James N. Ingle, Thomas C. Spelsberg posted to breast moa tamoxifen by misonneh on 2009-03-03 00:56:31 as
	A Century of Deciphering the Control Mechanisms of Sex Steroid Action in Breast and Prostate Cancer: The Origins of Targeted Therapy and Chemoprevention [My Copy] Cancer Res, Vol. 69, No. 4. (15 February 2009), pp. 1243-1254. by Craig V. Jordan posted to aromatase_inhibitor breast chemotherapy hormone moa prevention prostate review tamoxifen by misonneh on 2009-02-25 01:03:38 as
	Relevance of Breast Cancer Antiestrogen Resistance Genes in Human Breast Cancer Progression and Tamoxifen Resistance [My Copy] J Clin Oncol (15 December 2008), JCO.2008.17.1462. by Ton van Agthoven, Anieta M. Sieuwerts, Meijer-Van, et al.Maxime P. Look, Marcel Smid, Jos Veldscholte, Stefan Sleijfer, John A. Foekens, Lambert C. Dorssers posted to breast progression resistance tamoxifen by misonneh on 2009-02-20 00:47:18 as along with 2 people and 2 groups Zephyrus songpku Roswell Cancer Crosstalk Breast Cancer Reading Club
	The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer [My Copy] Breast Cancer Research and Treatment by Cynthia Osborne, Anita Duncan, Scot Sedlacek, et al.Devchand Paul, Frankie Holmes, Svetislava Vukelja, Michael Kasper, Sharon Wilks, Andrew Schneider, Richard Mcgee, Wally Meyer, Joyce O’shaughnessy posted to adr breast tamoxifen by misonneh on 2009-01-23 08:56:48 as
	Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen. [My Copy] Clinical pharmacology and therapeutics, Vol. 83, No. 5. (May 2008), pp. 702-710. by N. I. Ntukidem, A. T. Nguyen, V. Stearns, et al.M. Rehman, A. Schott, T. Skaar, Y. Jin, P. Blanche, L. Li, S. Lemler, J. Hayden, R. M. Krauss, Z. Desta, D. A. Flockhart, D. F. Hayes, Consortium on Breast Cancer Pharmacogenomics posted to breast esr1 estrogen tamoxifen by misonneh on 2009-01-23 08:35:35 as along with 1 person and 1 group Zephyrus Breast Cancer Reading Club
	Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism. [My Copy] Annals of Oncology, Vol. 19, No. 1. (January 2008), pp. 56-61. by J. Gjerde, M. Hauglid, H. Breilid, et al.S. Lundgren, J. E. Varhaug, E. R. Kisanga, G. Mellgren, V. M. Steen, E. A. Lien posted to breast cyp2d6 sult1a1 tamoxifen by misonneh on 2009-01-23 08:32:56 as
	Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer. [My Copy] Journal of Clinical Oncology, Vol. 25, No. 25. (1 September 2007), pp. 3837-3845. by H. S. Lim, Ju H. Lee, Seok K. Lee, Sook E. Lee, I. J. Jang, J. Ro posted to breast cyp2d6 pharmacogenetics pk tamoxifen by misonneh on 2009-01-23 08:27:21 as along with 2 people and 1 group lullaby HyeEun-Jeong Asian Pharmacogenetics Library
	Tamoxifen Pharmacogenomics: The Role of CYP2D6 as a Predictor of Drug Response [My Copy] Clin Pharmacol Ther, Vol. 83, No. 1. (2007), pp. 160-166. by M. P. Goetz, A. Kamal, M. M. Ames posted to cyp2d6 pharmacogenetics review tamoxifen by misonneh on 2009-01-23 06:42:23 as
	CYP450 pharmacogenetics for personalizing cancer therapy. [My Copy] Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, Vol. 11, No. 3. (June 2008), pp. 77-98. by R. H. van Schaik posted to breast chemotherapy pharmacogenetics review tamoxifen cyp450 by misonneh on 2009-01-23 06:20:27 as
	Pharmacogenetics in breast cancer therapy. [My Copy] Clinical Cancer Research, Vol. 14, No. 24. (15 December 2008), pp. 8027-8041. by S. H. Tan, S. C. Lee, B. C. Goh, J. Wong posted to breast chemotherapy pharmacogenetics review tamoxifen by misonneh on 2009-01-23 05:48:50 as along with 3 people and 2 groups HyeEun-Jeong songpku Zephyrus Asian Pharmacogenetics Library Breast Cancer Reading Club
	Multicenter Study Using Paraffin-Embedded Tumor Tissue Testing PITX2 DNA Methylation As a Marker for Outcome Prediction in Tamoxifen-Treated, Node-Negative Breast Cancer Patients [My Copy] J Clin Oncol, Vol. 26, No. 31. (1 November 2008), pp. 5036-5042. by Nadia Harbeck, Inko Nimmrich, Arndt Hartmann, et al.Jeffrey S. Ross, Tanja Cufer, Robert Grutzmann, Glen Kristiansen, Angelo Paradiso, Oliver Hartmann, Astrid Margossian, John Martens, Ina Schwope, Antje Lukas, Volkmar Muller, Karin Milde-Langosch, Jorg Nahrig, John Foekens, Sabine Maier, Manfred Schmitt, Ralf Lesche posted to breast gene_specific_methylation methylation pharmacogenetics tamoxifen target_dna by misonneh on 2009-01-22 04:25:53 as along with 1 person and 2 groups songpku Roswell Cancer Crosstalk Breast Cancer Reading Club
	Gene Testing to Predict Tamoxifen-Induced Hot Flashes: New Biological Insights [My Copy] J Clin Oncol, Vol. 26, No. 36. (20 December 2008), pp. 5841-5842. by Carolyn J. Crandall posted to adr comments genetics tamoxifen by misonneh on 2008-12-22 03:50:03 as
	Cellular and Molecular Pharmacology of Antiestrogen Action and Resistance [My Copy] Pharmacol Rev, Vol. 53, No. 1. (1 March 2001), pp. 25-72. by Robert Clarke, Fabio Leonessa, James N. Welch, Todd C. Skaar posted to chemotherapy resistance review tamoxifen by misonneh on 2008-12-09 04:03:38 as along with 1 person Zephyrus
	A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients? [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 9. (7 May 2008), pp. 610-613. by D. F. Hayes, V. Stearns, J. Rae, D. Flockhart, posted to breast comments cyp2d6 modeling resistance tamoxifen by misonneh on 2008-11-19 05:18:07 as
	Re: Pharmacogenomic variation of CYP2D6 and the choice of optimal adjuvant endocrine therapy for postmenopausal breast cancer: a modeling analysis. [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 18. (17 September 2008) by D. Gurwitz, W. Newman posted to breast comments cyp2d6 modeling pharmacogenetics survival tamoxifen by misonneh on 2008-11-19 05:17:27 as
	Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance. [My Copy] Clinical Cancer Research, Vol. 14, No. 18. (15 September 2008), pp. 5864-5868. by M. P. Goetz, V. J. Suman, F. J. Couch, et al.M. M. Ames, J. M. Rae, M. G. Erlander, X. J. Ma, D. C. Sgroi, C. A. Reynolds, W. L. Lingle, R. M. Weinshilboum, D. A. Flockhart, Z. Desta, E. A. Perez, J. N. Ingle posted to breast cyp2d6 resistance tamoxifen by misonneh on 2008-11-19 05:16:43 as
	Impaired tamoxifen metabolism reduces survival in familial breast cancer patients. [My Copy] Clinical Cancer Research, Vol. 14, No. 18. (15 September 2008), pp. 5913-5918. by W. G. Newman, K. D. Hadfield, A. Latif, et al.S. A. Roberts, A. Shenton, C. Mchague, F. Lalloo, S. Howell, D. G. Evans posted to breast cyp2d6 resistance survival tamoxifen by misonneh on 2008-11-19 05:16:11 as
	Association between CYP2D6 10 genotype and survival of breast cancer patients receiving tamoxifen treatment. [My Copy] Annals of Oncology*, Vol. 19, No. 8. (1 August 2008), pp. 1423-1429. by Y. Xu, Y. Sun, L. Yao, et al.L. Shi, Y. Wu, T. Ouyang, J. Li, T. Wang, Z. Fan, T. Fan, B. Lin, L. He, P. Li, Y. Xie posted to breast cyp2d6 survival tamoxifen by misonneh on 2008-11-14 08:26:28 as along with 2 people and 1 group Mi-Seon panwei Asian Pharmacogenetics Library
	Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis [My Copy] Nature, Vol. 438, No. 7070. (15 December 2005), pp. 981-987. by Huijian Wu, Yupeng Chen, Jing Liang, et al.Bin Shi, Ge Wu, Ying Zhang, Dan Wang, Ruifang Li, Xia Yi, Hua Zhang, Luyang Sun, Yongfeng Shang posted to endometrix epigenetics gene_specific_methylation moa pax2 tamoxifen by misonneh on 2008-10-17 16:43:02 as along with 1 person tuck
	Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant. [My Copy] Cancer Res, Vol. 66, No. 24. (15 December 2006), pp. 11954-11966. by M. Fan, P. S. Yan, C. Hartman-Frey, et al.L. Chen, H. Paik, S. L. Oyer, J. D. Salisbury, A. S. Cheng, L. Li, P. H. Abbosh, T. H. Huang, K. P. Nephew posted to breast epigenetics gene_specific_methylation global tamoxifen therapy by misonneh on 2008-10-17 16:41:07 as along with 2 people tonamswish jfr
	Effect of long-term tamoxifen exposure on genotoxic and epigenetic changes in rat liver: implications for tamoxifen-induced hepatocarcinogenesis. [My Copy] Carcinogenesis, Vol. 27, No. 8. (August 2006), pp. 1713-1720. by V. P. Tryndyak, L. Muskhelishvili, O. Kovalchuk, et al.R. Rodriguez-Juarez, B. Montgomery, M. I. Churchwell, S. A. Ross, F. A. Beland, I. P. Pogribny posted to dnmt epigenetics genetics invivo tamoxifen by misonneh on 2008-10-17 16:08:17 as
	Tamoxifen Chemoprevention Treatment and Time to First Diagnosis of Estrogen Receptor-Negative Breast Cancer [My Copy] J. Natl. Cancer Inst., Vol. 100, No. 20. (15 October 2008), pp. 1448-1453. by Yu Shen, Joseph P. Costantino, Jing Qin posted to breast diagnosis hr tamoxifen by misonneh on 2008-10-14 21:33:53 as along with 1 person and 2 groups songpku Roswell Cancer Crosstalk Breast Cancer Reading Club
	Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. [My Copy] Cancer research, Vol. 65, No. 4. (15 February 2005), pp. 1141-1145. by H. Fiegl, S. Millinger, E. Mueller-Holzner, et al.C. Marth, C. Ensinger, A. Berger, H. Klocker, G. Goebel, M. Widschwendter posted to biomarker breast circ_dna pharmacogenetics prognosis progression tamoxifen by misonneh on 2008-10-08 23:19:52 as along with 1 person c70238
	Association of DNA methylation of phosphoserine aminotransferase with response to endocrine therapy in patients with recurrent breast cancer. [My Copy] Cancer research, Vol. 65, No. 10. (15 May 2005), pp. 4101-4117. by J. W. Martens, I. Nimmrich, T. Koenig, et al.M. P. Look, N. Harbeck, F. Model, A. Kluth, J. Bolt-de Vries, A. M. Sieuwerts, H. Portengen, M. E. Meijer-Van Gelder, C. Piepenbrock, A. Olek, H. Höfler, M. Kiechle, J. G. Klijn, M. Schmitt, S. Maier, J. A. Foekens posted to breast methylation pharmacogenetics resistance tamoxifen by misonneh on 2008-09-23 21:16:26 as
	Tamoxifen resistance and epigenetic modifications in breast cancer cell lines. [My Copy] Current medicinal chemistry, Vol. 14, No. 28. (2007), pp. 3035-3045. by E. Badia, J. Oliva, P. Balaguer, V. Cavaillès posted to dynamic epigenetics methylation moa resistance review tamoxifen by misonneh on 2008-09-23 18:07:09 as along with 1 person and 1 group Zephyrus Roswell Cancer Crosstalk

Note: You may cite this page as: http://www.citeulike.org/user/misonneh/tag/tamoxifen

Result page: 1 2 Next

review	305
breast	260
genetics	162
epigenetics	161
methylation	153
pharmacogenetics	126
statistics	87
gene_specific_methylation	66
comments	65
gwas	63
biomarker	62
prognosis	60
association	53
tamoxifen	53
chemotherapy	47
moa	47
peripheral	47
gxe	46
diet	43
folate	40
modeling	38
guideline	35
resistance	35
survival	35
meta_analysis	34
global	33
prediction	33
response	32
epidemiology	31
epistasis	30
adr	29
dynamic	28
korean	28
technology	27
diagnosis	26
haplotype	26
prostate	26
time_to_event	25
cyp2d6	23
expression	23
race	23
neoadjuvant	22
circ_dna	21
colon	21
instability	21
environment	20
database	19
prevention	19
progression	18
lung	17
perspective	17
risk_factor	17
line1	16
pooling	16
therapy	16
immunity	14
target_dna	14
1-carbon	13
clinic	13
hr	13
invivo	13
phenotype	13
tool	13
5mdc	12
age	12
randomized_controlled_trial	12
tutorial	12
gxg	11
hematology	11
metastasis	11
mirna	11
pk	11
bladder	10
data_mining	10
estrogen	10
exposure	9
hormone	9
pathway	9
smoking	9
bias	8
cancer	8
design	8
esr1	8
fda	8
gst	8
heterogeneity	8
ivive	8
lifestyle	8
reproductive	8
cnv	7
dnmt	7
etiology	7
her2	7
hla	7
kim_	7
mdr1	7
metabolism	7
mthfr	7
power	7
prenatal	7
subtypes	7
trend	7
alcohol	6
carbamazepine	6
cell	6
cohort	6
cyp450	6
ddi	6
dna_repair	6
drug_discovery	6
epilepsy	6
histone	6
hyper_hypo	6
maternal	6
pcb	6
summary	6
system_biology	6
array	5
benign	5
cervix	5
chemoprevention	5
fundamental_concept_s1	5
inheritance	5
intervention	5
methodology	5
mgmt	5
mhc	5
microarray	5
mortality	5
nos3	5
pet	5
translation	5
asian_populations	4
balanced	4
basal-like	4
biobank	4
bmd	4
cimp	4
cns	4
detection	4
disparities	4
leukemia	4
linkage	4
ntissue	4
observation	4
pathology	4
refractory	4
transport	4
triple-negative	4
tsnp	4
aml	3
antioxidant	3
cluster	3
cyp1a1	3
cytokine	3
demethylation	3
fu	3
glioblastoma	3
hitchhiking	3
intrauterine	3
mds	3
metformin	3
molecular	3
public	3
ros	3
statin	3
sult1a1	3
sult1e1	3
swog	3
toxicity	3
validation	3
allergy	2
apoptosis	2
aromatase_inhibitor	2
aspirin	2
atm	2
bayesian	2
benzopyrene	2
bisphenol	2
brain	2
brca	2
brca12	2
caret	2
childhood	2
classification	2
comt	2
consorcium	2
cyp2c19	2
cyp2e1	2
decitabine	2
definition	2
diabetes	2
egfr_pathway	2
endometrix	2
epigenetic_therapy	2
feature_selection	2
finasteride	2
fprp	2
genotype	2
grail	2
hematopoiety	2
immortalization	2
insilico	2
irinotecan	2
iron	2
isoflavone	2
kawasaki	2
key	2
lymphoma	2
mnsod	2
nqo1	2
nutrition	2
oral	2
ovarian	2
ovary	2
parent_study	2
pharmacodynamic	2
phase	2
polycomb	2
protocol	2
quantitative_traits	2
radiotherapy	2
risk_assessment	2
s8897	2
slco1b1	2
specimen	2
testicular	2
toxicology	2
tpmt	2
ugt	2
wnt	2
abacavir	1
acs	1
aldh1	1
aldh2	1
alkylating_agents	1
alternative	1
anthracycline	1
antidepressant	1
assay	1
azacitidine	1
benzene	1
bmp	1
casp8	1
cat	1
catechol	1
cbr3	1
cdk	1
cell_cycle_control	1
cisplatin	1
cml	1
compliance	1
confounder	1
consortium	1
cyclophosphamide	1
cyp19	1
cyp1a2	1
cyp1b1	1
cyp2c9	1
cyp3a4	1
dag	1
dcic	1
decision	1
diganosis	1
digoxin	1
ecadherin	1
endpoint	1
epidgenetics	1
example	1
family_hx	1
fastsnp	1
fmr1	1
fun	1
glioma	1
gpx1	1
gstp1	1
heritability	1
hif1a	1
histology	1
history	1
hnscc	1
ho1	1
hogg1	1
hpv	1
illumina	1
immunoprecipitation	1
index	1
infection	1
inflammtion	1
integration	1
interleukin	1
invitro	1
journal_club	1
ki67	1
lactation	1
lipidadjust	1
liver	1
mapping	1
maspin	1
mbd2	1
metabolomics	1
meternal	1
methotrexate	1
mining	1
mpo	1
mrp3	1
multiple_myeloma	1
multitest	1
myc	1
networking	1
neurod1	1
nhs	1
no	1
nrf2	1
nsaid	1
nuclear_receptor	1
obesity	1
oncotypedx	1
opg	1
oralscc	1
osteoporosis	1
outcome	1
p53	1
parity	1
paternal	1
pax2	1
peakbmd	1
peripheral_blood	1
pharmacogenomics	1
pharmacokinetic_variability	1
phytoestrogen	1
plink	1
polymapr	1
polyphenol	1
population	1
practice	1
prevalence	1
proression	1
psychoses	1
qsar	1
rank	1
rcc	1
read_	1
resonse	1
rfc	1
s100p	1
sat2	1
scn	1
series	1
sfrp5	1
silencing_rna	1
splicing	1
sputum	1
src	1
steroid	1
stromal_component	1
tea	1
temozolomide	1
tgf	1
tgm2	1
tp53	1
twin_study	1
ugt1a1	1
warfarin	1
xpd	1
xrcc1	1
xrcc3	1

misonneh's tamoxifen [53 articles] Export

misonneh's tags